| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/20/2011 | US20110013476 Process and apparatus for producing a tabletting aid and also a tabletting aid and tabletting mixture |
| 01/20/2011 | CA2770980A1 Peptides whose uptake in cells is controllable |
| 01/20/2011 | CA2768444A1 Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
| 01/20/2011 | CA2768376A1 Methods and compositions for in vitro and in vivo chondrogenesis |
| 01/20/2011 | CA2768275A1 Improvements in and relating to colon cleansing compositions |
| 01/20/2011 | CA2768149A1 Stereoisomer peptides and their polymer conjugates for hiv disease |
| 01/20/2011 | CA2767833A1 N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen |
| 01/20/2011 | CA2767826A1 Mesenchymal stem cell differentiation using aniopoietin-like-3 |
| 01/20/2011 | CA2765220A1 Methods for inhibiting yellow color and peroxide formation in a composition |
| 01/19/2011 | EP2275557A1 Albumin fusion proteins |
| 01/19/2011 | EP2275548A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 01/19/2011 | EP2275449A1 Antibodies that immunospecifically bind to blys |
| 01/19/2011 | EP2275426A1 Metallo-organic system for the encapsulation and release of compounds of interest, method for obtaining same and uses thereof |
| 01/19/2011 | EP2275416A1 Biologically active methylene blue derivatives |
| 01/19/2011 | EP2275202A1 Carbonyl compound remover |
| 01/19/2011 | EP2275154A1 Antibacterial composition for medical use and medical device |
| 01/19/2011 | EP2275143A2 Conjugated anti-psychotic drugs and uses thereof |
| 01/19/2011 | EP2275142A2 Conjugates for immunotherapy of cancer |
| 01/19/2011 | EP2275141A1 Tastemasked pharmaceutical compositions |
| 01/19/2011 | EP2275094A2 Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions |
| 01/19/2011 | EP2275091A1 Pharmaceutical compositions comprising adsorbates of an amorphous drug |
| 01/19/2011 | EP2275089A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 01/19/2011 | EP2275085A1 Biodegradable copolymer suitable for delivering nucleic acid materials into cells |
| 01/19/2011 | EP2274043A1 Biodegradable metal-chelating polymers and vaccines |
| 01/19/2011 | EP2274018A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties |
| 01/19/2011 | EP2274017A2 Vascular delivery systems |
| 01/19/2011 | EP2274016A2 Use of pegylated igf-i variants for the treatment of neuromuscular disorders |
| 01/19/2011 | EP2274015A2 Controlled release of active agents from oleosomes |
| 01/19/2011 | EP2274014A2 Stabilized oleosome preparations and methods of making them |
| 01/19/2011 | EP2274011A2 An antibody bound synthetic vesicle containing active agent molecules |
| 01/19/2011 | EP2273993A1 Methods and compositions for the intracerebroventricular administration of felbamate |
| 01/19/2011 | EP2273986A2 Encapsulation of biologically active agents |
| 01/19/2011 | EP2273982A2 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 01/19/2011 | EP2273876A2 Stabilized compositions of alkylating agents and methods of using same |
| 01/19/2011 | EP2231131B1 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 01/19/2011 | EP2049157B1 Polymeric conjugates of doxorubicin with ph-regulated release of the drug and a method of preparing |
| 01/19/2011 | EP1757312B1 Freeze-dried composition of inactivated virus envelope with membrane fusion activity |
| 01/19/2011 | EP1683524B1 Solid dispersion or medicinal solid dispersion preparation of phenylalanine derivative |
| 01/19/2011 | EP1299108B1 A parasiticidal formulation and a method of making this formulation |
| 01/19/2011 | EP1185296B1 Prevention and treatment of amyloidogenic diseases |
| 01/19/2011 | EP1151749B1 Sheet-form adhesive preparation |
| 01/19/2011 | CN201710673U Cold compress pain relieving paste |
| 01/19/2011 | CN1929847B Fasudil-containing preparation and method of improving stability thereof |
| 01/19/2011 | CN1747748B Polymer derivatives having particular atom arrangements |
| 01/19/2011 | CN101952369A Optical imaging agents |
| 01/19/2011 | CN101952333A Polymer capable of adsorbing acidic water-soluble target substance, and method for production of the polymer |
| 01/19/2011 | CN101952311A G immunoglobulin used against anthrax toxins |
| 01/19/2011 | CN101951969A Composition for treatment of cartilage disease |
| 01/19/2011 | CN101951960A Conjugates of anti-RG-1 antibodies |
| 01/19/2011 | CN101951959A Anti-B7H4 monoclonal antibody-drug conjugate and methods of use |
| 01/19/2011 | CN101951958A Cholesterol derivatives of inhibitors of viral fusion |
| 01/19/2011 | CN101951957A Insulin formulations for insulin release as a function of tissue glucose levels |
| 01/19/2011 | CN101951956A Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 01/19/2011 | CN101951950A Vaccine |
| 01/19/2011 | CN101951935A Therapeutic agent for cerebral ischemic injury |
| 01/19/2011 | CN101951923A Liquid nucleotides/nucleosides-containing product |
| 01/19/2011 | CN101951922A Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material |
| 01/19/2011 | CN101951896A Composite preparation |
| 01/19/2011 | CN101951887A Liquid antiseptic compositions containing iodine and a sugar and/or sugar alcohol |
| 01/19/2011 | CN101951886A Enhancing photostabilization of oxymetazoline |
| 01/19/2011 | CN101951885A Formulation |
| 01/19/2011 | CN101951884A Compositions and methods for the treatment of bladder cancer |
| 01/19/2011 | CN101951790A A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 01/19/2011 | CN101951783A Composition comprising protein and disperse fat |
| 01/19/2011 | CN101951762A Foam stabilizer composition |
| 01/19/2011 | CN101948543A Fusion protein and coding gene and application thereof |
| 01/19/2011 | CN101948541A Compositions and methods for the diagnosis and treatment of tumor |
| 01/19/2011 | CN101948507A Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof |
| 01/19/2011 | CN101948506A Finasteride conjugate and application thereof to preparation of medicament for treating prostate |
| 01/19/2011 | CN101948444A synthesized small molecular compound capable for transferring bioactive substances and applications thereof |
| 01/19/2011 | CN101947324A Macromolecule based preparation method of pH-responsive metal-organic coordination polymer |
| 01/19/2011 | CN101947323A Gram negative bacterium vaccine and preparation method thereof |
| 01/19/2011 | CN101947322A Gel patch matrix and preparation method and application thereof |
| 01/19/2011 | CN101947321A Heat-resisting and freeze-drying protector for live vaccine and preparation method thereof as well as live newcastle disease vaccine |
| 01/19/2011 | CN101947320A Mesoporous silicon/polymer composite controlled release medicament carrier, preparation method and application thereof |
| 01/19/2011 | CN101947313A Novel effervescent tablet for treating beriberi and preparation process thereof |
| 01/19/2011 | CN101947309A Human basic fibroblast growth factor eye drops and preparation method thereof |
| 01/19/2011 | CN101947264A Chinese and western compound suppository for treating dog endometritis and preparation method thereof |
| 01/19/2011 | CN101947258A Film-spraying agent for treating bovine mastitis |
| 01/19/2011 | CN101947251A Method for preparing chickpea isoflavone microcapsules |
| 01/19/2011 | CN101947237A Externally-applied hypochlorous acid liquid with functions of oxidizing, disinfecting, expelling and removing toxins |
| 01/19/2011 | CN101947220A Combined medicament of omeprazole sodium |
| 01/19/2011 | CN101947219A Compound telmisartan amlodipine besylate medicinal composition and preparation method thereof |
| 01/19/2011 | CN101947214A Method for preparing vitamin A microcapsules by secondary emulsification and spray drying method |
| 01/19/2011 | CN101947212A Micro-embedded medicament carrier and preparation method thereof |
| 01/19/2011 | CN101947211A Method for preparing acetylcysteine effervescent tablet |
| 01/19/2011 | CN101947210A Levoamlodipine besylate liposome tablet |
| 01/19/2011 | CN101947207A Preparation method of tylosin tartrate microspheres |
| 01/19/2011 | CN101947206A Method for preparing recombinant pancreotropic hormone secretion peptide medicament microspheres |
| 01/19/2011 | CN101947205A Novel galanthamine sustained-release preparation and preparation method thereof |
| 01/19/2011 | CN101947204A Neo-gambogic acid SLN (solid lipid nanoparticle) and preparation method thereof |
| 01/19/2011 | CN101947200A Emulsion type ointment |
| 01/19/2011 | CN101947199A Nifedipine mucilage and preparation method thereof |
| 01/19/2011 | CN101947194A Methods and compositions for use with gel dispensers |
| 01/19/2011 | CN101627986B Acedofenac-paracetamol pharmaceutical composite and liposome solid preparation thereof |
| 01/19/2011 | CN101584665B Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof |
| 01/19/2011 | CN101579324B Method for preparing omeprazole enteric fast-release tablet |
| 01/19/2011 | CN101543477B Sustained-release microsphere of chitosan-coated 3,5-dihydroxy-4-isopropyl toluylene and preparation method thereof |
| 01/19/2011 | CN101507708B Preparation method of liposome |
| 01/19/2011 | CN101507707B Fasudil hydrochloride lipo-microballoons carrier preparation and preparation method thereof |